KAPA · Kairos Pharma, LTD. · Webcasts, Transcripts & Audio
$0.54
0.00 (-0.18%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has experienced recurring losses from operations since inception and incurred a net loss of $3,042 and used cash in operations of $2,048 during the six months ended June 30, 2026. These factors raise substantial doubt about the Company's ability to continue as a going concern. In addition, the Company's independent registered public accounting firm, in its report on the Company's December 31, 2025 financial statements, has expressed substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$1.84M
Shares
3.39M
Volume · Oct 23
108.1K
Avg daily vol (38 sessions)
568.33K
Kairos Pharma, LTD. Webcasts
Earnings calls, investor updates, investor days and conferences for Kairos Pharma, LTD. (KAPA), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
No Webcasts Available
No webcast events are available for this stock yet.